0208080893 [email protected]
Providers / Bioss Primary Conjugated Antibodies. ALEXA FLUOR / HHV8 ORF50 Antibody, ALEXA FLUOR 594

Description:

Size: 100ul

Catalog no.: bs-0859R-A594

Price: 380 EUR

Get for 380 EUR on Gentaur.com

/ningbo-assets-bio/graphics/prods/bigs/bigs7.jpg

Product details

Modification Site

None

Cross-reactive species details

HHV8

Virus

hhv8

Crossreactivity

Virus

French translation

anticorps

Tested applications

IF(IHC-P)

Target Antigen

HHV8 ORF50

Modification

Unmodified

Clonality

Polyclonal

Excitation emission

590nm/617nm

Immunogen range

500-550/691

Concentration

1ug per 1ul

Conjugated

Alexa conjugate 1

Conjugated with

ALEXA FLUOR® 594

Recommended dilutions

IF(IHC-P)(1:50-200)

Clone

Polyclonal antibody

Purification

Purified by Protein A.

Category

Conjugated Primary Antibodies

Conjugation

Alexa Fluor,ALEXA FLUOR® 594

Host Organism

Rabbit (Oryctolagus cuniculus)

Also known as

Anti-HHV8 ORF50 PAb ALEXA FLUOR 594

Specificity

This is a highly specific antibody against HHV8 ORF50.

Long name

HHV8 ORF50 Polyclonal Antibody, ALEXA FLUOR 594 Conjugated

Source

This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human HHV8/ORF50

Synonyms

HHV8 ORF50; HHV 8; Human Herpes Virus 8; Human herpesvirus 8; Kaposi's sarcoma associated herpes virus; Kaposi's sarcoma associated herpesvirus; KSHV.

Storage conditions

Store this antibody in aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Keep refrigerated at 2 to 8 degrees Celcius for up to one year.

Properties

For facs or microscopy Alexa 1 conjugate.If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies. ALEXA FLUOR they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.

Background of the antigen

HHV8 has been found to be associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.